Sponsors submitting trial information to ClinicalTrials.gov should do a better job submitting results data because their submissions to date have been “downright embarrassing,” ClinicalTrials.gov Director Deborah Zarin said at a meeting of the FDA’s Risk Communication Advisory Committee. The data often are inconsistent, and some entries “simply can’t be true,” she added.
Clinical Trials Advisor